Sign Up to like & get
recommendations!
0
Published in 2019 at "Advanced healthcare materials"
DOI: 10.1002/adhm.201801510
Abstract: Antiretroviral (ARV) drugs have, for many years, been studied and administered in the prevention and treatment of human immunodeficiency virus (HIV). Intramuscular (IM) injection of long acting (LA) ARVs are in clinical development, but injectable…
read more here.
Keywords:
microarray patches;
delivery;
dissolving microarray;
rpv ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Advanced Drug Delivery Reviews"
DOI: 10.1016/j.addr.2021.01.022
Abstract: The COVID-19 pandemic is a serious threat to global health and the global economy. The ongoing race to develop a safe and efficacious vaccine to prevent infection by SARS-CoV-2, the causative agent for COVID-19, highlights…
read more here.
Keywords:
development skin;
microarray patches;
skin;
patches enable ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.0c00431
Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) can cause harmful and potentially deadly infections. Vancomycin remains the first-line antibiotic treatment for MRSA-derived infections. Nevertheless, as a peptide drug, it is poorly absorbed when administered orally due to its…
read more here.
Keywords:
transdermal delivery;
microarray patches;
delivery vancomycin;
delivery ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02612-18
Abstract: Using a murine model of Klebsiella pneumoniae bacterial infection, we demonstrate that gentamicin dissolving microarray patches, applied to murine ears, could control K. pneumoniae infection. Mice treated with microarray patches had reduced bacterial burden in…
read more here.
Keywords:
gentamicin;
pneumoniae infection;
infection;
dissolving microarray ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2022.1037157
Abstract: Background Progress toward measles and rubella (MR) elimination has stagnated as countries are unable to reach the required 95% vaccine coverage. Microarray patches (MAPs) are anticipated to offer significant programmatic advantages to needle and syringe…
read more here.
Keywords:
microarray patches;
coverage;
pdr;
scenario ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2022.809675
Abstract: Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding,…
read more here.
Keywords:
measles rubella;
rubella microarray;
microarray patches;
progress ... See more keywords